Lv41
530 积分 2024-09-09 加入
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group
8小时前
已完结
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group
9小时前
已完结
Assessment of pain in rheumatic diseases
14天前
已关闭
[Consensus of clinical diagnosis and treatment of premature ovarian insufficiency (2023)]
4个月前
已完结
[Recommendations for diagnosis and treatment of systemic sclerosis in China]
6个月前
已完结
Development of Regulation and Policy for Cell Therapies in China
7个月前
已完结
[Recommendations for the diagnosis and treatment of Sjögren's syndrome in China]
7个月前
已完结
[Recommendations for diagnosis and treatment of systemic sclerosis in China]
8个月前
已完结
皖公网安备34019202002308
